XML 77 R38.htm IDEA: XBRL DOCUMENT v3.23.1
CAPITAL STOCK (Tables)
12 Months Ended
Dec. 31, 2022
Disclosure of terms and conditions of share-based payment arrangement [abstract]  
Disclosure of detailed information about number and weighted average exercise prices of share options [Table Text Block]
    Number     Weighted Average
Exercise Price (C$)
 
Balance as at December 31, 2020   6,382,400   $ 1.70  
Granted   1,801,500     3.98  
Exercised   (1,055,400 )   1.33  
Forfeited   (20,000 )   3.96  
Balance as at December 31, 2021   7,108,500   $ 2.33  
Granted   1,970,500     2.55  
Exercised   (1,110,000 )   1.22  
Forfeited   (120,000 )   3.07  
Number of options outstanding as at December 31, 2022   7,849,000   $ 2.53  
Disclosure of detailed information about exercise prices of outstanding share options [Table Text Block]
Date Granted   Number of Options     Exercisable     Exercise Price($C)   Expiry Date
July 10, 2018   1,264,000     1,264,000     1.30   July 10, 2023
November 28, 2018   10,000     10,000     1.57   November 28, 2023
December 14, 2018   20,000     20,000     1.42   December 14, 2023
June 6, 2019   1,335,000     1,335,000     1.70   June 6, 2024
November 18, 2019   30,000     30,000     1.80   November 18, 2024
January 21, 2020   60,000     60,000     2.22   January 21, 2025
April 22, 2020   20,000     20,000     2.50   April 22, 2025
June 10, 2020   1,406,500     1,406,500     2.62   June 10, 2025
October 5, 2020   24,000     24,000     3.50   October 5, 2025
May 6, 2021   1,206,500     1,206,500     4.11   May 6, 2026
May 12, 2021   15,000     15,000     4.28   May 12, 2026
June 21, 2021   20,000     20,000     3.67   June 21, 2026
August 19, 2021   500,000     500,000     3.66   August 19, 2026
September 8, 2021   10,000     10,000     3.51   September 8, 2026
April 29, 2022*   1,817,000     1,797,000     2.56   April 29, 2027
July 5, 2022   100,000     100,000     2.45   July 5, 2027
July 20, 2022   11,000     11,000     2.45   July 20, 2027
                     
Total   7,849,000     7,829,000          

* Includes options granted for investor relations services that vest 25% every 4 months from the date of grant.

Disclosure of detailed information about restricted share units [Table Text Block]
    Number  
Balance as at December 31, 2020   1,076,000  
Vested   (326,500 )
Granted   470,000  
Balance as at December 31, 2021   1,219,500  
Vested   (241,750 )
Forfeited   (77,750 )
Granted   520,000  
Balance as at December 31, 2022   1,420,000  
Disclosure of detailed information about restricted share units outstanding [Table Text Block]
Evaluation Date   December 31, 2021     Granted     Vested     Expired/Cancelled     December 31, 2022  
December 31, 2021*   312,500     -     (234,750 )   (77,750 )   -  
November 18, 2022*   7,000     -     (7,000 )   -     -  
December 31, 2022**   430,000     -     -     -     430,000  
December 31, 2023   470,000     -     -     -     470,000  
December 31, 2024   -     520,000     -     -     520,000  
Total   1,219,500     520,000     (241,750 )   (77,750 )   1,420,000  

*Based on the achievement of performance as evaluated by the Compensation Committee, 241,750 RSUs with evaluation dates of December 31, 2021 and November 18, 2022 had vested based on preset performance criteria previously established on the grant date. Of the 241,750 vested, 70% being 164,063 were paid in shares and the balance modified and settled in cash.

**As at December 31, 2022 the RSU's with an evaluation date of December 31, 2022 have not yet been determined to have vested or expired.

Disclosure of detailed information about warrants, activity [Table Text Block]
    Number     Weighted Average
Exercise Price (C$)
 
             
Balance as at December 31, 2020   -   $ -  
Issued   3,399,280     3.98  
Balance as at December 31, 2021   3,399,280     3.98  
Issued   3,812,121     4.45  
Expired   (149,282 )   3.50  
Balance as at December 31, 2022   7,062,119   $ 4.47  
Disclosure of detailed information of warrants outstanding [Table Text Block]
Date Issued   Number of Warrants     Exercisable     Exercise Price (C$)     Expiry Date  
November 5, 2021   3,249,998     3,249,998     4.50     November 5, 2023  
April 14, 2022   3,812,121     3,812,121     4.45     April 14, 2027  
Total   7,062,119     7,062,119              
Disclosure of detailed information about share-based payment arrangements [Table Text Block]
Year ended Deceember 31, 2022   General and
Administrative
Expenses
    Royalty Generation
Costs
    Total  
Fair value of stock options vested $ 962   $ 795   $ 1,757  
RSU's vested   1,530     142     1,672  
  $ 2,492   $ 937   $ 3,429  
 
Year ended December 31, 2021   General and
Administrative
Expenses
    Royalty Generation
Costs
    Total  
Fair value of stock options vested $ 1,403   $ 1,205   $ 2,608  
RSUs vested   1,285     -     1,285  
RSUs settled in cash   247     22     268  
  $ 2,935   $ 1,226   $ 4,161  
Disclosure of detailed information about options, valuation assumptions [Table Text Block]
    December 31, 2022     December 31, 2021  
Risk free interest rate   2.76%     0.88%  
Expected life (years)   5     5  
Expected volatility   48.7%     53.3%  
Dividend yield   0%     0%